| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 06/12/2024 | 22:20 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 04/12/2024 | 22:36 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 26/11/2024 | 22:05 | GlobeNewswire Inc. | PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024 | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 31/10/2024 | 21:02 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 30/10/2024 | 21:05 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 30/10/2024 | 01:43 | GlobeNewswire Inc. | PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 28/10/2024 | 21:19 | GlobeNewswire Inc. | PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 28/10/2024 | 21:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 28/10/2024 | 12:00 | PR Newswire (US) | Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 28/10/2024 | 12:00 | GlobeNewswire Inc. | PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 28/10/2024 | 11:12 | IH Market News | US Futures Rise; Oil Prices Drop Over 5% as Middle East Tensions Ease | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 09/10/2024 | 22:04 | GlobeNewswire Inc. | PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024 | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 07/10/2024 | 22:04 | GlobeNewswire Inc. | PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 28/08/2024 | 22:03 | GlobeNewswire Inc. | PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024 | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 21/08/2024 | 13:00 | GlobeNewswire Inc. | PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 01/08/2024 | 22:03 | GlobeNewswire Inc. | PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 15/07/2024 | 22:03 | GlobeNewswire Inc. | PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024 | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 17/06/2024 | 22:03 | GlobeNewswire Inc. | PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 03/06/2024 | 22:03 | GlobeNewswire Inc. | PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024 | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 13/05/2024 | 22:05 | GlobeNewswire Inc. | PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 06/05/2024 | 14:00 | GlobeNewswire Inc. | Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 01/05/2024 | 13:00 | GlobeNewswire Inc. | PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 29/04/2024 | 14:00 | GlobeNewswire Inc. | Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 23/04/2024 | 14:00 | GlobeNewswire Inc. | PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 04/04/2024 | 22:04 | GlobeNewswire Inc. | PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 02/04/2024 | 22:03 | GlobeNewswire Inc. | PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024 | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 27/02/2024 | 22:02 | GlobeNewswire Inc. | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 12/02/2024 | 22:05 | GlobeNewswire Inc. | PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 08/02/2024 | 23:30 | GlobeNewswire Inc. | CTS Corporation Announces Appointment of Amy M. Dodrill to its Board of Directors | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |
| 08/01/2024 | 23:00 | GlobeNewswire Inc. | PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million | NASDAQ:PRCT | PROCEPT BioRobotics Corporation |